EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:138502 - etazolate
| Formula | C14H19N5O2 |
| Net Charge | 0 |
| Average Mass | 289.339 |
| Monoisotopic Mass | 289.15387 |
| SMILES | CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C |
| InChI | InChI=1S/C14H19N5O2/c1-5-19-13-10(8-16-19)12(18-17-9(3)4)11(7-15-13)14(20)21-6-2/h7-8H,5-6H2,1-4H3,(H,15,18) |
| InChIKey | OPQRBXUBWHDHPQ-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | phosphodiesterase IV inhibitor An EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor that specifically blocks the action of phosphodiesterase IV. alpha-secretase activator An activator of α-secretase, one of the three endopeptidases that are specific for amyloid protein precursor and which have been identified based upon the region of the amyloid protein precursor which they cleave. GABA agent A substance, such as agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function, used for its pharmacological actions on GABAergic systems. |
| Applications: | anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. GABA agent A substance, such as agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function, used for its pharmacological actions on GABAergic systems. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| etazolate (CHEBI:138502) has role antidepressant (CHEBI:35469) |
| etazolate (CHEBI:138502) has role antipsychotic agent (CHEBI:35476) |
| etazolate (CHEBI:138502) has role anxiolytic drug (CHEBI:35474) |
| etazolate (CHEBI:138502) has role GABA agent (CHEBI:51374) |
| etazolate (CHEBI:138502) has role neuroprotective agent (CHEBI:63726) |
| etazolate (CHEBI:138502) has role phosphodiesterase IV inhibitor (CHEBI:68844) |
| etazolate (CHEBI:138502) has role α-secretase activator (CHEBI:88355) |
| etazolate (CHEBI:138502) is a ethyl ester (CHEBI:23990) |
| etazolate (CHEBI:138502) is a hydrazone (CHEBI:38532) |
| etazolate (CHEBI:138502) is a pyrazolopyridine (CHEBI:46699) |
| IUPAC Name |
|---|
| ethyl 1-ethyl-4-(2-isopropylidenehydrazino)-1H-pyrazolo[3,4-b]pyridine-5-carboxylate |
| INNs | Source |
|---|---|
| etazolate | WHO MedNet |
| étazolate | WHO MedNet |
| etazolato | WHO MedNet |
| etazolatum | WHO MedNet |
| Synonyms | Source |
|---|---|
| 1-ethyl-4-(2-propan-2-ylidenehydrazinyl)-5-pyrazolo[3,4-b]pyridinecarboxylic acid ethyl ester | LINCS |
| 1H-pyrazolo(3,4-b)pyridine-5-carboxylic acid, 1-ethyl-4-((1-methylethylidene)hydrazino)-, ethyl ester | SUBMITTER |
| EHT-0202 | ChEBI |
| ethyl 1-ethyl-4-[2-(1-methylethylidene)hydrazino]-1H-pyrazolo[3,4-b]pyridine-5-carboxylate | SUBMITTER |
| ethyl 1-ethyl-4-(2-isopropylidenehydrazino)pyrazolo[3,4-b]pyridine-5-carboxylate | SUBMITTER |
| ethyl 1-ethyl-4-(2-propan-2-ylidenehydrazinyl)pyrazolo[3,4-b]pyridine-5-carboxylate | SUBMITTER |
| Registry Numbers | Sources |
|---|---|
| Reaxys:548872 | Reaxys |
| CAS:51022-77-6 | ChemIDplus |
| Citations |
|---|